Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
Title:
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
Author:
Marks, David I Kirkwood, Amy A Rowntree, Clare J Aguiar, Melanie Bailey, Katharine E Beaton, Brendan Cahalin, Paul Castleton, Anna Z Clifton-Hadley, Laura Copland, Mhairi Goldstone, Anthony H Kelly, Richard Lawrie, Emma Lee, SooWah McMillan, Andrew K McMullin, Mary Frances Menne, Tobias F Mitchell, Rachel J Moorman, Anthony V Patel, Bela Patrick, Pip Smith, Paul Taussig, David Yallop, Deborah Alapi, Krisztina Zuborne Fielding, Adele K
Appeared in:
The Lancet. Haematology
Paging:
Volume 9 () nr. 4 pages e262-e275
Year:
2022
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license